vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与KKR Real Estate Finance Trust Inc.（KREF）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.9倍（$25.8M vs $13.7M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -101.7%，领先91.4%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -26.6%），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs -18.8%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
CPIX vs KREF — 直观对比
营收规模更大
KREF
是对方的1.9倍
$13.7M
营收增速更快
CPIX
高出57.7%
-26.6%
净利率更高
CPIX
高出91.4%
-101.7%
两年增速更快
CPIX
近两年复合增速
-18.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $25.8M |
| 净利润 | $-1.4M | $-26.2M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | -105.1% |
| 净利率 | -10.3% | -101.7% |
| 营收同比 | 31.1% | -26.6% |
| 净利润同比 | 25.8% | -229.6% |
| 每股收益（稀释后） | $-0.09 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXKREF
| Q4 25 | $13.7M | $25.8M | ||
| Q3 25 | $8.3M | $25.3M | ||
| Q2 25 | $10.8M | $30.2M | ||
| Q1 25 | $11.7M | $31.3M | ||
| Q4 24 | $10.4M | $35.1M | ||
| Q3 24 | $9.1M | $37.0M | ||
| Q2 24 | $9.8M | $40.4M | ||
| Q1 24 | $8.5M | $39.1M |
净利润CPIXKREF
| Q4 25 | $-1.4M | $-26.2M | ||
| Q3 25 | $-1.9M | $13.8M | ||
| Q2 25 | $-740.7K | $-29.7M | ||
| Q1 25 | $1.3M | $-4.9M | ||
| Q4 24 | $-1.9M | $20.3M | ||
| Q3 24 | $-1.5M | $-7.4M | ||
| Q2 24 | $-1.1M | $25.8M | ||
| Q1 24 | $-1.9M | $-3.1M |
毛利率CPIXKREF
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXKREF
| Q4 25 | -10.0% | -105.1% | ||
| Q3 25 | -23.7% | 50.4% | ||
| Q2 25 | -6.9% | -101.3% | ||
| Q1 25 | 11.0% | -18.3% | ||
| Q4 24 | -17.7% | 55.8% | ||
| Q3 24 | -18.6% | -19.6% | ||
| Q2 24 | -10.4% | 63.3% | ||
| Q1 24 | -22.0% | -8.7% |
净利率CPIXKREF
| Q4 25 | -10.3% | -101.7% | ||
| Q3 25 | -23.4% | 54.4% | ||
| Q2 25 | -6.8% | -98.5% | ||
| Q1 25 | 10.7% | -15.5% | ||
| Q4 24 | -18.2% | 57.7% | ||
| Q3 24 | -17.0% | -20.0% | ||
| Q2 24 | -11.0% | 63.9% | ||
| Q1 24 | -22.9% | -7.9% |
每股收益（稀释后）CPIXKREF
| Q4 25 | $-0.09 | $-0.49 | ||
| Q3 25 | $-0.13 | $0.12 | ||
| Q2 25 | $-0.05 | $-0.53 | ||
| Q1 25 | $0.08 | $-0.15 | ||
| Q4 24 | $-0.13 | $0.22 | ||
| Q3 24 | $-0.11 | $-0.19 | ||
| Q2 24 | $-0.08 | $0.29 | ||
| Q1 24 | $-0.14 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $1.2B |
| 总资产 | $76.8M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXKREF
| Q4 25 | $11.4M | $84.6M | ||
| Q3 25 | $15.2M | $204.1M | ||
| Q2 25 | $16.1M | $107.7M | ||
| Q1 25 | $15.1M | $106.4M | ||
| Q4 24 | $18.0M | $104.9M | ||
| Q3 24 | $17.5M | $108.8M | ||
| Q2 24 | $17.3M | $107.2M | ||
| Q1 24 | $18.5M | $106.5M |
股东权益CPIXKREF
| Q4 25 | $24.9M | $1.2B | ||
| Q3 25 | $26.1M | $1.2B | ||
| Q2 25 | $28.0M | $1.2B | ||
| Q1 25 | $28.7M | $1.3B | ||
| Q4 24 | $22.9M | $1.3B | ||
| Q3 24 | $24.8M | $1.4B | ||
| Q2 24 | $26.3M | $1.4B | ||
| Q1 24 | $27.5M | $1.4B |
总资产CPIXKREF
| Q4 25 | $76.8M | $6.5B | ||
| Q3 25 | $65.9M | $6.5B | ||
| Q2 25 | $67.9M | $6.8B | ||
| Q1 25 | $69.9M | $6.6B | ||
| Q4 24 | $75.6M | $6.4B | ||
| Q3 24 | $76.7M | $6.8B | ||
| Q2 24 | $78.5M | $7.1B | ||
| Q1 24 | $81.5M | $7.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $72.3M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
经营现金流CPIXKREF
| Q4 25 | $3.0K | $72.3M | ||
| Q3 25 | $187.2K | $18.5M | ||
| Q2 25 | $843.8K | $21.1M | ||
| Q1 25 | $3.9M | $15.9M | ||
| Q4 24 | $1.9M | $132.6M | ||
| Q3 24 | $475.5K | $49.1M | ||
| Q2 24 | $-855.7K | $30.6M | ||
| Q1 24 | $-2.1M | $34.5M |
自由现金流CPIXKREF
| Q4 25 | $3.0K | — | ||
| Q3 25 | $163.4K | — | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | — | ||
| Q2 24 | $-862.8K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXKREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | -8.8% | — | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXKREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率CPIXKREF
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
